Clinical trials
Myopia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
193 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 11 |
| 2019 | 9 |
| 2020 | 18 |
| 2021 | 10 |
| 2022 | 23 |
| 2023 | 29 |
| 2024 | 18 |
| 2025 | 21 |
| 2026 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 65 |
| Unknown status | 51 |
| Recruiting | 39 |
| Not yet recruiting | 18 |
| Active, not recruiting | 16 |
| Enrolling by invitation | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Eye Disease Prevention and Treatment Center | 31 |
| Tianjin Eye Hospital | 23 |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | 19 |
| Beijing Tongren Hospital | 14 |
| Sun Yat-sen University | 13 |
| The Hong Kong Polytechnic University | 12 |
| Beijing Airdoc Technology Co., Ltd. | 5 |
| Ruihua Wei | 5 |
| Wenzhou Medical University | 5 |
| He Eye Hospital | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myopia | 193 |
| Refractive Errors | 29 |
| Astigmatism | 9 |
| Myopia, Degenerative | 7 |
| Hyperopia | 6 |
| Eye Diseases | 5 |
| Cataract | 3 |
| Amblyopia | 2 |
| Lacerations | 2 |
| Presbyopia | 2 |
Trials
Showing 1 to 25 of 193. Each trial links to its page on Pharma Observatory.
93 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.